相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KPC-12 with a L169M substitution in the ω loop has reduced carbapenemase activity
Jiayuan Qin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
KPC-Mediated Resistance to Ceftazidime-Avibactam and Collateral Effects in Klebsiella pneumoniae
Jacqueline Findlay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals
Mariana Castanheira et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
Rodrigo E. Mendes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae
Siqiang Niu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
KPC-50 Confers Resistance to Ceftazidime-Avibactam Associated with Reduced Carbapenemase Activity
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Resistance to Ceftazidime/Avibactam plus Meropenem/Vaborbactam When Both Are Used Together Is Achieved in Four Steps in Metallo-β-Lactamase-Negative Klebsiella pneumoniae
Punyawee Dulyayangkul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
KPC Beta-Lactamases Are Permissive to Insertions and Deletions Conferring Substrate Spectrum Modifications and Resistance to Ceftazidime-Avibactam
Claire Amaris Hobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
Jodie C. Hamrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired beta-lactam resistance
Juan-Carlos Jimenez-Castellanos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Effect of Porins and blaKPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?
Gregory Balabanian et al.
MICROBIAL DRUG RESISTANCE (2018)
Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes
Wan Ahmad Kamil Wan Nur Ismah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D179Y Substitution in the KPC-2 β-Lactamase
Fabrice Compain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase
Eva Torres et al.
MICROBIAL DRUG RESISTANCE (2016)
Outbreak of Klebsiella pneumoniae producing a new carbapenern hydrolyzing class a β-lactamase, KPC-3, in a New York Medical Center
N Woodford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
分享论文
